Mainz, August 10, 2018 – The new Helmholtz Institute “HI-TRON Mainz” aims to develop effective immunotherapies and identify new biomarkers for cancer treatments.
HI-TRON is a collaboration between the German Cancer Research Center (DKFZ) and the research institute TRON – Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz. Cooperation agreements have now been signed.
“By founding of HI-TRON Mainz, we are pursuing the mission of establishing a world-leading center for personalized cancer immunotherapy. HI-TRON Mainz thus engenders the Helmholtz spirit by acting as a catalyst for groundbreaking technologies, sustainable translation of academic innovation and its clinical implementation for the benefit of patients, “so Ugur Sahin, founder and scientific director of TRON.